课题基金 / 基金详情

PDT--MECHANISMS AND STRATEGIES FOR OPTIMIZATION

PDT--MECHANISMS AND STRATEGIES FOR OPTIMIZATION
PDT--优化机制和策略
批准号:
6150112
负责人:
ALLAN R OSEROFF
金额:
$157.66万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2003-01-31

项目摘要

项目成果

ALLAN R OSEROFF的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall goals of the Program Project are to gain an increased understanding of the mechanisms of photodynamic therapy (PDT) and to optimize treatment parameters. This will be achieved through the following individual research projects: 1. New, congeneric series of photosensitizers will be prepared and characterized, in order to elucidate those parameters which are important for optimal activity and those which are irrelevant. Quantitative data will be obtained which allow use of multi-dimensional QSAR models, and the predictive value of these models will be examined. The relationship between effective sensitizers and their ability to bind to specific intracellular sites will be examined. 2. The kinetics and tissue distributions of certain cytokines which are induced in vivo by PDT via oxidative stress mechanisms will be explored. The hypotheses that these cytokines can, at least in part, account for the immunopotentiating as well as immunosuppressive effects of PDT will be examined. 3. The questions of whether intracellular binding sites of effective photosensitizers are primarily mitochondrial and if the peripheral benzopdiazepine receptor in this organelle is important in sensitizer binding will be explored. The hypothesis that mitochondrial and PBR- associated sensitizers are important in inducing photodamage and the physiological responses which lead to cell death will be explored. 4. Surrogate variables which will provide real-time and short-term information on the underlying mechanistic processes and probably outcomes in clinical PDT and permit tailoring of the therapy to individual patients and lesions will be developed. As a general paradigm, light dose and dose rate effects will be explored in ALA-PDT with different ALA application times in basal cell carcinomas and cutaneous lymphomas, with examination of the photochemical and biological processes contributing to differences in efficacy, efficiency and selectivity. The Program will be supported by three important technical Core components and an Administrative Core.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative
Administrative
Novel Cancer Nanotechnology Platforms for Photodynamic *
Novel Cancer Nanotechnology Platforms for Photodynamic Therapy and Imaging